Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16092
Title: Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No
Austin Authors: Krishnananthan, Nishanth;Lawrentschuk, Nathan
Affiliation: Austin Health, Heidelberg, Victoria, Australia
University of Melbourne, Department of Surgery, Austin Health, Melbourne, Australia
Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Issue Date: Jun-2016
Publication information: International Brazilian Journal Of Urology 2016 May-June; 42(3): 418-421
URI: http://ahro.austin.org.au/austinjspui/handle/1/16092
DOI: 10.1590/S1677-5538.IBJU.2016.03.04
ORCID: 0000-0001-8553-5618
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27286102
Type: Journal Article
Subjects: Prostatic Neoplasms
Prostate cancer
Disease
Therapeutics
Watchful waiting
Appears in Collections:Journal articles

Show full item record

Page view(s)

2
checked on Dec 6, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.